Navigation Links
Chemists create 'Superbowl' molecule; May lead to better health

f the superbowl molecule lacks solubility in water, which could compromise its potential medical applications, the researcher says. Superbowl molecules also have the potential to be toxic. But Sherburn and his associates are confident these potential problems can be solved with further testing and some clever chemical engineering.

Funding for this study was provided by The Australian National University. In addition to Sherburn, study authors include Elizabeth S. Barrett and Alison J. Edwards, also with Australian National University; and Jacob L. Irwin, of the University of Sydney.

The American Chemical Society is a nonprofit organization, chartered by the U.S. Congress, with a multidisciplinary membership of more than 159,000 chemists and chemical engineers. It publishes numerous scientific journals and databases, convenes major research conferences and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio.


'"/>

Source:


Page: 1 2 3

Related biology news :

1. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
2. Chemists identify key gene in development of type 1 diabetes
3. Chemists identify immune system mechanism for methamphetamine binges
4. Chemists synthesize molecule that helps body battle cancers, malaria
5. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
6. RNA project to create language for scientists worldwide
7. Researcher gets NSF grant to create mutant maize lines
8. Breakthrough: Scientists create worlds tiniest organic particles
9. NIH creates nationwide network of molecular libraries screening centers
10. Researchers create infectious hepatitis C virus in a test tube
11. Ants, not evil spirits, create devils gardens in the Amazon rainforest, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chemists create Superbowl molecule May lead better health

(Date:4/17/2014)... Razzari of the nergie Matriaux Tlcommunications Research Centre ... John R. Evans Leaders Fund of the Canada ... state-of-the-art biotech and nanophotonics equipment. To this funding ... de l,Enseignement suprieur, de la Recherche, de la ... laboratories will help us develop new approaches for ...
(Date:4/17/2014)... University engineer has developed a patented technique that ... devices. The same technique could help police during ... and Kay L. Theede chair in engineering and ... his research team have created a template-based system ... trunks. The distance detection method called stand-off ...
(Date:4/17/2014)... is available in German . ... the protection money demanded of him, he can expect his ... however, as fear of the consequences is enough to make ... parasitic birds, which lay their eggs in other birds, nests. ... brood parasites take their revenge by destroying the entire nest. ...
Breaking Biology News(10 mins):New state-of-the-art biotech and nanotech equipment for INRS 2Patented research remotely detects nitrogen-rich explosives 2Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3
... PHILADELPHIA -- Scientists are another step closer to ... there are factors inside tumors that can slow their ... Cancer Research , a journal of the American Association ... researcher at the division of experimental medicine at the ...
... A recent study led by researchers at Boston University School ... mortality among patients diagnosed with severe sepsis and new-onset atrial ... assistant professor of medicine at BUSM and a pulmonologist at ... study, which will be published in the Journal of the ...
... SAN FRANCISCO Combining the investigational agents REGN910 ... effects in animal models compared with either agent ... International Conference: Molecular Targets and Cancer Therapeutics, held ... findings suggest that combining REGN910 (SAR307746) and aflibercept ...
Cached Biology News:BUSM: Severe sepsis, new-onset AF associated with increased risk of hospital stroke, death 2Combination therapy shows potent tumor growth inhibition in preclinical studies 2
(Date:1/15/2014)... Freeslate, Inc ., the leading ... Lupin Limited, one of India’s top five pharmaceutical companies, ... System for high throughput solid form screening. ... a wide range of quality, affordable generic and branded ...
(Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
(Date:1/14/2014)... SAN DIEGO and BETHESDA, Md. ... they are joining together with two institutes from the ... more reliable tools for bringing safer, more effective treatments ... with the National Center for Advancing Translational Sciences (NCATS) ...
(Date:1/14/2014)...   Kinaxis ®, provider of RapidResponse ®, a cloud-based ... planning ( S&OP ) service, is proud to be a ... be held at the Hilton San Diego Bayfront, January 30 ... Elisabeth Kaszas , Director of Supply Chain at Amgen, as ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... Dr. Pollard Brings the Highest Level of Clinical ... Feb. 1 Genetic,Immunity(R), a US/Hungarian clinical-stage biopharmaceutical ... patented,immunotherapeutic platform technology, announced that it has appointed,Richard ... Dr. Pollard has been a leader in HIV/AIDS ...
... N.J., Feb. 1 Amicus Therapeutics,Inc. (Nasdaq: FOLD ... Executive Officer, will present a corporate update at the ... York, NY on Thursday, February 7, 2008 at 11:40 ... The presentation will be webcast live and may be ...
... 31 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... of common stock at a price of $27.00,per share. ... The underwriters,have an option to purchase up to an ... is expected to close on February 6,2008, subject to ...
Cached Biology Technology:Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 3Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 3Rigel Announces Pricing of Public Offering of Common Stock 2
a1-Antitrypsin (human, alpha-1 AT)...
... vesicles are used to study co-translational ... Processing events such as signal peptide ... glycosylation can be examined by the ... vitro in the presence of these ...
... using Mo Bio luciferase assay. Mo Bio Laboratories ... will allow you to certify your products ATP-Free ... you to deliver them to your customers in ... limit is 3.5 x 10-12 /l, which will ...
... New Concept in Microarrays: Biomedical Photometrics Inc. ... GmbH (Jena, Germany) have collaborated to develop ... ArrayTube System. The DNAscope AT is ... new DNAscope AT automatically reads up to ...
Biology Products: